New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis

Key Points

• Access to CAR T-cell therapies for children's cancer requires breaking down existing barriers, enhancing availability.
• Key findings from the multistakeholder analysis show critical challenges that hinder effective development and delivery of therapies.
• Approach includes a thorough multistakeholder analysis to identify key factors affecting access and development of CAR T-cell therapies.
• Implications highlight the need for collaborative efforts across sectors to improve access for vulnerable populations.